Xtalks to Host Webinar on AI and Molecular Advances in Hematologic Cancer Drug Development

April 14, 2026
Xtalks will host a free webinar on April 30, 2026, focusing on how molecular reclassification, minimal residual disease, and AI are transforming precision hematology. Experts from NeoGenomics and Fortrea will discuss AI-driven diagnostics and molecular endpoints in cancer research.

In a press release, Xtalks announced a free webinar titled "Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology," scheduled for April 30, 2026, at 11 a.m. EDT. The event will explore how molecular reclassification and artificial intelligence are influencing precision medicine in hematologic cancers.

The session will feature Maria Prendes, Head of Scientific Affairs at NeoGenomics, and Maria Ignacia Berraondo, Executive Medical Director at Fortrea. They will discuss the use of molecular residual disease (MRD) as a surrogate endpoint in drug development and the role of AI-driven digital hematopathology in improving diagnostic precision.

The webinar aims to highlight how integrating molecular diagnostics, multi-omic data, and AI-based predictive modeling can accelerate therapeutic assessment and refine patient stratification in hematologic malignancies. Registration for the event is open through the Xtalks website.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

04/14
Axxess AGILE 2026 Conference to Focus on Responsible AI in Home Care
04/14
Sunbound Launches AI-First Revenue OS for Senior Living
04/14
Caristo Diagnostics Names Stephen Deitsch as CEO
04/14
Briya Expands Global Health Data Network to 120 Million Patient Journeys
04/14
Spirographic AI Launches Tissue-Specific Drug Target Prediction Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like